ATTENTION ALL CUSTOMERS:
Due to a recent change in our pharmacy software system, the process for submitting refill requests online has now changed.
Our previous mobile app and your current login credentials will no longer work.
Please click the Refill Online tab to begin the new process.
Thank you for your patience during this transition.

Manténgase sano!

  • Posted June 25, 2024

Healthy Weight Loss Could Lower Your Odds for Cancer

Losing weight can protect you against cancers related to obesity, a new study finds.

Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin.

But study results show that dropping pounds can improve a person's odds against developing these cancers, including breast, kidney, ovary, liver and pancreatic cancers.

"This study reinforces how crucial it is to treat obesity as a chronic disease,"said researcher Dr. Kenda Alkwatli, a clinical fellow at Cleveland Clinic. "We are hopeful that these results can help us better understand how we can use weight loss to address co-morbidities, including cancer in patients with obesity."

For the study, researchers evaluated the electronic health records of more than 100,000 obese patients at the Cleveland Clinic, of whom more than 5,300 developed cancer.

Researchers tracked changes in BMI at three-, five- and 10-year intervals prior to a person's cancer diagnosis and compared them against controls.

They found that losing weight could reduce a person's risk of developing most obesity-related cancers within a five-year span.

For example, the risk of kidney cancer dropped within three years and endometrial cancer at three and five years. Multiple myeloma risk fell within 10 years.

What's more, losing weight also appeared to protect people against a range of 16 other cancers that haven't been linked to obesity, researchers found.

These included melanoma and cancers of the skin, lungs, genitalia, eye, brain and digestive organs.

Researchers next intend to see if anti-obesity drugs like Wegovy and Zepbound can cut cancer risk.

The researchers presented their results Friday at the American Diabetes Association's annual meeting in Orlando, Fla. Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

More information

The National Cancer Institute has more on obesity and cancer.

SOURCE: American Diabetes Association, news release, June 21, 2024

El servicio de noticias de salud es un servicio para los usuarios de la página web de Cave City Pharmacy gracias a HealthDay. Cave City Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.
Derechos de autor © 2024 HealthDay Reservados todos los derechos.